XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength

Author: Bruce Powers
Published: August 25, 2026

Overview

The SPDR S&P Biotech ETF (XBI) has shown significant strength, recently reaching a new trend high and setting the stage for a critical test of resistance at the 2021 peak of $174.79. This article analyzes the recent performance of XBI, highlighting key technical patterns and potential future movements.

Current Performance

XBI has advanced to a new trend high of $169.89, following a bullish flag breakout. This movement was supported by the highest weekly trading volume in eight weeks, indicating strong market participation. The ETF has established a higher swing low at $161.49, suggesting that as long as it remains above this level, the bullish bias will continue.

Technical Analysis

The recent breakout from a small three-day bullish flag pattern has put the 2021 peak of $174.79 directly in focus. The price action indicates a potential large basing pattern, with the right side of the base nearing the left side. If resistance at this level persists, it could lead to the formation of a handle in a cup-with-handle pattern, which is a bullish signal.

Market Dynamics

Despite the bullish trend, there are concerns about overextension as the ETF has risen approximately 155% since its swing low of $66.66 in April 2025. This rapid increase raises the possibility of a pullback or consolidation phase, especially as it approaches significant resistance at $174.79.

Key Levels to Watch

The $174.79 level is crucial for determining the next steps for XBI. A breakout above this resistance could lead to further gains, while a failure to break through may result in a consolidation period that could ultimately form a handle, reducing the risk of a sharp pullback.

Conclusion

XBI is at a pivotal point, with the potential for a long-term base breakout. Investors should closely monitor the $174.79 resistance level, as it will likely dictate the ETF's direction in the near term. The balance between continued bullish momentum and the risk of overextension will be key in the coming weeks.